Back to News
Market Impact: 0.15
Study Unveils ‘Plug-and-Play’ CAR T Technology Designed to Adapt as Cancer Changes
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
City of Hope announced an adaptable, “plug-and-play” CAR T-cell technology designed to be updated after treatment as tumors evolve. The development could improve the durability and flexibility of CAR T therapies, but the release provided no clinical-efficacy, regulatory, or commercial data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- Wall Street’s Nasdaq hits all-time high as AI frenzy gathers pace
- Data-Center Bet Makes ESDS One of India’s Best New Listings
- Asia stocks ride tech wave higher, oil stays subdued
- U.S. regulators rush to write crypto rulebook after Clarity Act stalls in Senate
- Meta is breaking out after introducing Muse AI agent. Where the stock is going, according to the charts
- Anthropic in talks to lease 1 gigawatt from Stream Data Centers- The Information